KYTHERA Biopharmaceuticals, Inc. is a privately held biopharmaceutical company focused on science and innovation in aesthetic medicine.

This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company applies the tools of biotechnology to develop prescription therapeutics for this emerging market.

KYTHERA has active programs in adipolysis, facial contouring and pigmentation modulation.